These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 33511948)

  • 1. The Prospect for Type 2 Diabetes Mellitus Combined with Exercise and Synbiotics: A Perspective.
    Dewi L; Rosidi A; Noer ER; Ayuningtyas A
    Curr Diabetes Rev; 2021; 17(8):e012821190875. PubMed ID: 33511948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics, prebiotics, synbiotics and insulin sensitivity.
    Kim YA; Keogh JB; Clifton PM
    Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synbiotic Intervention with an Adlay-Based Prebiotic and Probiotics Improved Diet-Induced Metabolic Disturbance in Mice by Modulation of the Gut Microbiota.
    Chiou WC; Chang BH; Tien HH; Cai YL; Fan YC; Chen WJ; Chu HF; Chen YH; Huang C
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Synbiotics (Prebiotics and Probiotics) as Dietary Supplements in Type 2 Diabetes Mellitus Induced Health Complications.
    Baghel K; Khan A; Kango N
    J Diet Suppl; 2024; 21(5):677-708. PubMed ID: 38622882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.
    Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD
    Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial.
    Zeinali F; Aghaei Zarch SM; Vahidi Mehrjardi MY; Kalantar SM; Jahan-Mihan A; Karimi-Nazari E; Fallahzadeh H; Hosseinzadeh-Shamsi-Anar M; Rahmanian M; Fazeli MR; Mozaffari-Khosravi H
    Trials; 2020 Apr; 21(1):324. PubMed ID: 32290852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials.
    Paul P; Kaul R; Harfouche M; Arabi M; Al-Najjar Y; Sarkar A; Saliba R; Chaari A
    Pharmacol Res; 2022 Nov; 185():106520. PubMed ID: 36272640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probiotic, prebiotic, and synbiotic on the gut microbiota of autistic children using an in vitro gut microbiome model.
    Duque ALRF; Demarqui FM; Santoni MM; Zanelli CF; Adorno MAT; Milenkovic D; Mesa V; Sivieri K
    Food Res Int; 2021 Nov; 149():110657. PubMed ID: 34600659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study.
    Horvath A; Leber B; Feldbacher N; Tripolt N; Rainer F; Blesl A; Trieb M; Marsche G; Sourij H; Stadlbauer V
    Eur J Nutr; 2020 Oct; 59(7):2969-2983. PubMed ID: 31729622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics, prebiotics, and synbiotics added to dairy products: Uses and applications to manage type 2 diabetes.
    Zepeda-Hernández A; Garcia-Amezquita LE; Requena T; García-Cayuela T
    Food Res Int; 2021 Apr; 142():110208. PubMed ID: 33773683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota-Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics.
    Dahiya D; Nigam PS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into dominant intestinal microbiota and the fatty acids profile of turkeys following the administration of synbiotic preparations.
    Markowiak-Kopeć P; Śliżewska K; Lipiński K
    J Sci Food Agric; 2022 Sep; 102(12):5272-5287. PubMed ID: 35303378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential therapeutic effects of the gut microbiome manipulation by synbiotic containing-Lactobacillus plantarum on neuropsychological performance of diabetic rats.
    Morshedi M; Saghafi-Asl M; Hosseinifard ES
    J Transl Med; 2020 Jan; 18(1):18. PubMed ID: 31924200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.
    Vakilpour A; Amini-Salehi E; Soltani Moghadam A; Keivanlou MH; Letafatkar N; Habibi A; Hashemi M; Eslami N; Zare R; Norouzi N; Delam H; Joukar F; Mansour-Ghanaei F; Hassanipour S; Samethadka Nayak S
    Nutr Diabetes; 2024 May; 14(1):25. PubMed ID: 38729941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a Synbiotic Formula on Functional Bowel Disorders and Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN): A Pilot Study.
    D'Onofrio V; Del Chierico F; Belci P; Vernocchi P; Quagliariello A; Reddel S; Conta G; Mancino MV; Fadda M; Scigliano MC; Morelli R; De Francesco A; Guagnini F; Fassio F; Galletti R; Putignani L
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33383954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-targeted therapies for type 2 diabetes mellitus: A review.
    Xu TC; Liu Y; Yu Z; Xu B
    World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.